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In this study , skin-infiltrating ce ll s in psoriasis patients were 
characterized in biopsies from both involved and uninvolved 
skin. Histologic examination ofbiopsies showed the presence 
of both C04+ and COS+ T cells and the lack of B lympho-
cytes. Skin biopsies w ere also placed in tissue culture m edium 
supplem ented with human serum, interleukin-2 (IL-2) , and 
irradiated autologous blood lymphocytes. T lymphocytes 
grew from both plaques and uninvolved skin biopsies and 
consisted of a he terogeneous population of T-ee!! subsets . 
The immunophenotypic analysis of cui tured cells was compa-
rable to the histologic examination on frozen section, 
P soriasis is a chronic intractable skin disease, character-ized by inflammation and rapid epidermal proliferation (1- 9]. A major controversy in psorias is research is whether psoriasis is fundamentally an immunologic dis-order or is the result of unregul ated keratinocyte growth 
and differentiation. 
It is conceivable that the defect resides within the keratinocyte 
itself (10, 11]. Alternatively, hyperproliferation of keratinocytes 
may represent a secondary response to inflammatory factors released 
from the epidermis (10] . Another theory of the etiology of psoriasis 
is that th e disease may be due to an abnormality of the immune 
response and that T lymphocytes, or their products, can regulate 
epidermal proliferation [12]. 
The presence of abnormalities in periph eral blood lymphocytes 
(PEL) of psoriasis patients has been controversial (13 -25]. Several 
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Abbreviations: 
CML: cell-mediated lympholysis 
DRC: dendritic reticular cel ls 
FITC: fluorescein isothiocyanate 
H&E: hematoxylin and eosin 
HLA: human leukocyte antigens 
IL-2: intcrlcukin-2 
LCA: leukocyte common anti gens 
LCL: lymphoblastoid ce ll line 
MoAb: monoclonal antibody 
NK: natural killer 
PBL: periph era l blood lymphocytes 
PL T: primed lymphocyte test 
TCM: tissue cultu re media 
i.e. , there was a greater number of C04/COw29+ cells than 
COS+ /C04S+ cells. Cultures were tested in the primed 
lymphocyte test (PL T) and cell-mediated lympholysis 
(CML) assays . All cultures tested d emonstrated secondary 
proliferative but not cytoly tic reactivity . The PLT results 
indicate that the cell cultures generated are autoreactive. This 
autoreactivity was found to be directed against non-human 
leukocy te antigens (HLA), i. e ., minor HLA with some re-
striction to major HLA antigens.] In11est D erma to! 96:3-9, 
1991 
studies (9,13 - 15], including an investigation by this group,* have 
shown the lack of abnormalities in PBL of psoriasis patients. Due to 
these results and the presence of abnormali ties in skin, more atten-
tion has been focused on studying the skin and skin-infiltrating cells 
in psorias is patients. 
In an attempt to investi gate the types and functions of infiltrating 
cells, we obtained skin biopsies from psoriatic plaques and clinically 
uninvolved areas. Lymphocytes cultured from biopsies were char-
acterized for their phenotypes by staining with monoclonal antibod-
ies and for their functions by testing th em in a cel l-mediated lym-
pholysis assay (C ML), a natural killer (NK) assay, and primed 
lymphocyte tes ting (PLT) . W e have also examined the characteris-
tics of cultured lymphocytes and phenotypes in correlation with the 
pathologic examination and histologic grade of cellular infiltration 
of corresponding skin biopsies. 
MATERIALS AND METHODS 
Patients Six patients with severe psoriasis (> SO% body surface 
area involvement) , were selected. N o systemic therapy had been 
used by patients for 3 weeks prior to obtaining the biopsy specimens. 
Three healthy individuals were biopsied as controls. 
Biopsy Specimens Three-millimeter punch biopsies were taken 
from each patient. Two were from psoriatic plagues and one was 
from clinically uninvo lved skin. Uninvolved biopsies were taken 
from the center of a large clinica lly normal area distant from where 
the involved biopsies were obtained. For controls, biopsies were 
obtamed from the forearms of three healthy individuals. Punch 
biopsy specimens were placed in RPMI medium for transport to the 
laboratory. 
*Gilbert SC, Nikae in A, Ne_wmat:JT~ Silverman A, Stone MJ, Menrer A: 
Cyclosponn A and pson asts: mvesuganon of humoral and cell mediated 
immune function (submitted) . 
0022-202X/91/S 03 .50 Copyright © 1991 by The Society for Inves tigative Dermatology, Inc. 
3 
4 N IKAEIN ET AL 
TOTAL NUMBER 
140 48 
C022 COIS COS CD4 CD3 C012CD11C LCA Ia DRC 
MoAbs 
-EPIDERMIS -PERIVASCULAR 
Figure 1. Histopathologic examination of skin biopsies from involved 
(plaque) areas. Solid bars, epidermis; hate /z ed bars, perivascular mliltratmg 
cell s. Results are the means of skin biopsies from fi ve patients. Nu mbers above 
the ba rs represent SE. 
Histologic Examination of Biopsies The portions of th e sk~n 
biopsies used for histopathologic evaluation were snap frozen 1~ 
isopentane, quenched in liquid nitrogen, and stored at -70oC unt1l 
the time of study. Serial cryostat sections were fi xed in 4 o C acetone 
for 10 min and immunohistochemically stained by a three-stage 
biotin-avidin immunoperoxidase system. The panel of monoclonal 
antibodies (MoAb} (Becton-Dickinson) to ce ll-surface ant1 gens 
used included the following: Leu 14 (CD22: pan B cells), Leu 1 
(CDS: panT cell s), Leu 2 (C D8 suppressor/cytotoxic T cells), Leu 
3a (C D4 : helper T cells), Leu 4 (C D3: pan T cell s), Leu 6 
(C D11 : anti-thymocyte/Langerh ans), Leu M S (anti-monocyte/ 
macroph ages), LC A (leukocyte common antigens), Ia (HLA-DR), 
and DRC (dendritic reticular cells). A section from each biopsy was 
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Figure 2. Histopathologic examination of skin biopsies from uninvolved 
areas. Solid bars, epidermal; hatched bars, perivascular infiltrating cells. Results 
arc the mea ns of sk in biopsies from fi ve patients. Nu mbers abo11e t!ze bars 
represe nt SE. The lack of SE indicates that only the cells of one biopsy could 
be evaluated for that particular MoAb. 
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of the specimen. A semi-quantitative estimate of B and T lympho-
cytes, macrophages, Langerhans cells, and dendritic reticul ar ce ll s in 
each biopsy was obtained by counting the absolute number of cells 
stained with the respective antibodies in the three most cellular 
high-power fi elds of the epidermis and of a perivascular location in 
the dermis. 
Generation of Cell Lines from Skin Biopsies Each biopsy was 
divided into small fragments and placed in tissue culture medium 
(TCM} supplemented with gentamicin, human AB serum, and 25% 
interleukin-2 (IL-2) (Boehringer & Mannheim) . Irradiated autolo-
gous peripheral blood lymphocytes (1 X 106) were added to each 
culture. Cultures were examined daily for growth on an inverted 
microscope. C ultures were replenished with new media th ree times 
a week and with feeder cell s once every 7-10 d. When a large 
number of growing cells was observed, the contents of a well were 
divided and placed into two separate wells and th e process contin-
ued until a number of cell s sufficient for examination was obtained. 
Phenotype Analysis of Cell Lines Cul tured cells from skin 
biopsies (5 X 105) were incubated for 30 min at room temperature 
with 10 ).ll of two monoclonal antibodies (Coulter clones), one la-
beled with FITC and one labeled with phycoerythrin. The panel of 
two-color MoAb used in this analysis included: T11 / B 1 (C D2/ 
CD20), T4/ T 8(CD4/CD8), T4/ 4B4(CD4/CD29), T 8/ 
2H4(CD8/CD45R) , T 8/NK(C D8/CD56), and T3/ 13(C D3/ 
HLA-Class II or Ia). Cells were was hed twice with 
phosphate-buffered saline and fixed in 10% paraformaldehyde. The 
percentage of FITC- and phycoerythrin-stained cells was measured 
by ortho flow cytometry. 
Functional Assays 
Primed Lymphocyte Test (PLT) : PLT assay was performed as 
previously described (26] . Briefly, 2 X 104 cultured cells were incu-
bated for 3d with 2.5 X 104 homozygous lymphoblas toid cell lines 
(LCL) or 1 X 105 full y HLA-typed PBL, as well as with autologous 
LCL or PBL. C ultures were labeled with 3H-thymidine 18 h prior 
to harvesting of the cells. Proliferation was determined by 3H -th y-
midine uptake measured by a beta-scintillation counter. 
Cell-Mediated Lympholysis (CML): Skin-infil trating cells (effector 
cells, 2.5 X 1 OS, 1.25 X 105, or 5 X 1 04) were incubated for 4 h 
with 5 X 103 51ch romium (51Cr)-labeled autologous or all ogeneic 
LC L or K5 62 cells (targets of NK cells). C ultures were centrifuged 
for 5 min at 1000 rpm, then 0.1 ml of supernate was removed and 
counted in a gamma counter (27]. Percentage of lysis was deter-
mined by the follow ing formula: 
E-S Ofo lys is =-- X 100 T-S ' 
w ith E being the experimental 51C r release , S the spontaneous 51Cr 
released from th e target cells alone, and T the total released by 
incubating the target ce lls with 0.1 ml of 5% triton. 
Statistic Analysis Statistic analysis to calculate the p values was 
performed by Student t test. 
RESULTS 
Histopathologic Examination of Skin Sections of th e biopsies 
of psoriatic plagues stained with H &E showed the characteristic 
histopathologic changes of psoriasis, whereas sections of the biop-
sies of uninvolved skin had minor path ologic changes , with fewer 
infiltra ting mononuclear cell s. In sections stained immunohisto-
chemically with the various monoclonal antibodies, the majority of 
the mononuclear cells present in both normal and abnormal skin 
were T lymphocytes and stained with C DS , C D8 , C D4, C D3, 
LCA, and/ or Ia monoclonal antibodies. Only very few samples 
contained isolated B cells (CD22+), whereas dendritic reticul ar cell s 
were absent in all biopsies. The relative proportion of the cell s from 
involved and uninvolved skin stained with MoAb are shown in Figs 
1 and 2, respectively. There were no statistically significant differ-
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Figure 3. Gro:-vth of skin-infiltrating ce lls in TCM substituted with IL-2 and ~utologous feeder cells. A, growth ofT cells (rep:esented as four clumps) from 
biopsies of psonas1s patients; B, absence of growth ofT lymphocytes from bwps1es of normal volunteers. In these cultu res, the epithelial-like cells that covered 
the bottoms of the wells died in a few weeks. 
ences in the populations of mononuclear cell s present in involved 
and uninvolved areas of skm. 
Generation of Cell Lines from Skin Biopsies In order to per-
form functional studies, we expanded the skin-infiltrating cells in 
TCM. All specimens from both involved and uninvolved skin grew 
larger numbers of cells in the presence of irradiated feeder cells (Fig 
3A). In contras t, cells from biopsies obtained from normal volun-
teers fai led to grow (Fig 3B). The growth of lymphocytes in such a 
conditioned medium, which supports the growth of only activated 
T cells, is consistent with the presence of activated lymphocytes in 
the skin of psorias is patients, regardless of the presence of clinical 
lesions. 
Phenotype Characterization of Cell Lines from Skin 
Biopsies Phenotypes of nine cultures, from biopsies of four pa-
tients, were analyzed by flow cytometry. Results showed cells to be 
positive for CD2, CD3, CD4, CD8, CDw29 (helper-inducer T 
cells), CD45RA (suppressor-inducer T cells), CD 56 (NK cells), and 
HLA-class II (Ia) (Figs 4 and 5) . The percentages of CD3+ and 
CD8+ T cell s among the cell lines of involved skin areas were 
significantly higher than those of uninvolved skin (p < 0.03 for 
both populations). By contrast, there was a significantly lower per-
centage of CD4 cells among the cell lines expanded from the in-
volved areas of skin, compared to those from uninvolved areas (p < 
0.05) . CD4+ and CDw29+ cells outnumbered CD8+ and 
CD45RA +cells, respectively. The differences, however, were not 
statistically significant. About 50% of the cells expressed class II 
HLA, which is indicative ofT-cell activation. On individual base 
analysis, CD45RA +cells outnumbered CDw29 in two of the biop-
sies, and a considerable number of CD56/CD8-positive cells were 
noted in one. Clinically, there were no differences between these 
three and the other patients. 
Functional Assays 
PLT: In order to determine the reactivity of infiltrating cells, we 
mixed cells cultured from biopsies with various numbers of autolo-
gous or allogeneic LCL or PBL. T he list of the cell panels and their 
HLA types is shown in T able I. Proliferation was measured as an 
indication of recognition of antigenic determinants by the respon-
der cells. 
The PL T results were calculated as percent relative response and 
designated as positive restimulation val ues, according to a cluster 
analysis (28]. Based on this analysis, with use of a software program, 
resu lts were expressed as responder-normalized val ues, equating the 
75th ranked response to 100%. Numbers equal to or greater than 
100% were considered to be a positive response . Table II illustrates 
results from one patient's skin biopsy cultures. Autologous cells 
stimulated these cultures, as did 13 of 29 unrelated cells . No com-
mon HLA antigen was found to be shared by the patient's cells and 
the cell lines that generated positive responses. Fifteen other unre-
lated cells did not significantly stimulate these cultures, although 
various HLA antigens were shared w ith the recipient. Table III 
illustrates the PL T results from a second patient's skin biopsy cul-
ture. Again, significant stimulation was observed by autologous 
stimulator cells. No HLA specificity cou ld be detected because no 
HLA antigens were shared by the 12 stimulator cells giving positive 
responses. In addition, some cell lines that did not stimulate cultured 
cells shared some antigens with the patient. Similarly, the results of 
PL T of a third (Table IV) and fourth patient (Table V) revealed 
significant stimulation by autologous cells and some of the unre-
lated cell lines. Again, no HLA specificity could be designated. It is 
important to note that the HLA-DP of the patients was not deter-
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Figure 4. Representation of the phenotype of skin-infiltrating cells ex-
panded in TCM. Cells were stained with two-color Coulter clones MoAb 
and analyzed by flow cytometty. Results are the means of five analyses from 
involved skin biopsies of four patients. Numbers above the bars represent 
standard errors. 
mined. However, no common HLA-OP antigen was found among 
all the cell lines that stimulated the cultures. It is also important to 
notice that the majority of cell lines that restimulated patients' cell 
cultures shared at least one HLA antigen with the patient. A few 
that did not may share the HLA-OP, although this remains to be 
determined. These patterns of reactivity are in accordance with 
recognition of minor HLA antigens that could be restricted by some 
elements, e.g., major HLA determinants. 
CML: In this experimental design, skin-infiltrating cell lines were 
tes ted for specific lysis of autologous or selected allogeneic LCL 
sharing class I or class II major histocompatibility complex antigens 
with each patient. In addition, the K562 cell line was used as a target 
for NK cell lysis. None of the targets tested was lysed by any of the 
skin biopsy cultures (results not shown). 
DISCUSSION 
Infiltration of mononuclear cells into psoriatic skin lesions has long 
been recognized, but data regarding their functional characteristics 
have been lacking. It has been suggested that the accumulation of 
these cells may be the principal mechanism whereby psoriatic le-
sions are initiated and maintained [7,29-31] . In this study, several 
unique observations have been made regarding the skin of psoriatic 
patients. We demonstrated that the infiltration of mononuclear 
cells is not I imited to psoriatic plaques. Both histopathologic exami-
nation of biopsies and culture of cells indicated the presence of 
mononuclear cells in uninvolved areas of skin, as well as in the 
involved areas, although the numbers in the uninvolved areas were 
remarkably lower. The majority of these cells were found to be T 
lymphocytes. Functional studies of the infiltrating cells indicated 
autoreactivity with possible specificity towards minor HLA anti-
gens, and the absence of cytolytic and NK activity . 
Histopathologic examination of biopsies revealed marked mono-
nuclear cell infiltration of psoriatic plaques, whereas changes in 
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Figure 5. Representation of the phenotype of skin-infiltrating cells ex-
panded in TCM. Cells were stained with two-color Coulter clones MoAb 
and analyzed by flow cytometry. Results are the means of four analyses from 
uninvolved skin biopsies of 2 patients. Numbers above the bars represent SE. 
uninvolved skin were minimal. NoB cells or dendritic cells were 
found among the infiltrating cells. Similar to the findings of others 
(30), this is con~istent with the notion that B lymphocytes and 
antt~ody are not mvolved 111 the mduction of psoriatic plaques. The 
c~mmtent growth ofT lymphocytes in cultures from various biop-
sies suggests that both involved and uninvolved areas of skin were 
infiltrated with "activated" T lymphocytes . 
The phenotype analyses of cultured cells were similar to those 
obtaine? by histologic examination, with the major cell being the 
helper-mducer T lymphocyte. There were no differences between 
the types of cells obtained from lesions and those from uninvolved 
s~in. It is interestin~ that Baker et al (30] reported the presence of 
different subp?pulat10ns ofT lymphocytes in older versus younger 
plaques. In this study , we compared only the cells from uninvolved 
skin with those from involved skin and found no differences. The 
expression of class II HLA molecules by infiltrating cells is not 
surprising, as activated T lymphocytes usually express these markers 
(31- 35]. The results of our study indicate that there is an abnormal 
infiltration of both C04-positive and COS-positive T cells. In one 
case, we also found increased numbers of COS+ cells and C0 56+ 
cells (NK cells). These populations have been isolated from both 
involved and uninvolved areas of skin or psoriasis patients. There-
fore, it is possible that the initiation of clinical lesions is not charac-
terized by any detectable changes in the number of, and types of, the 
infiltrating cells. 
Assays were conducted to understand the functions these cells 
may play in the induction of psoriasis . The unique observation in 
this study is that all the cell lines demonstrated autoreactivity, i.e., 
proliferated in culture with autologous PBL. This is significant 
because the etiology of psoriasis has been postulated for some time 
to be due to autoreactivity induced by the presence of autoreactive 
T-hel£er cells or the absence of self-regulatory suppressor lympho-
cytes [36-38] . The autoreactivity appeared to be toward non-HLA 
antigens, presumably minor HLA antigens, because the cell lines 
giving rise to a positive response did not share a particular HLA 
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Table I. HLA Type of Ce ll Lines Used in PLT Assays 
Ce ll Name A B DR DQw 
AMAI 28 5 15(2) 6 
BER 2 13 7 2 
BM92 25 62 4 3,8 
BOB 2 62 4 
BRIP 9 5 11 (5) 3 
EHM 3 35 1 
H0 104 3 7 15(2) 6 
JBUSH 32 38 11 (5) 3 
KT12 29 5 9 3 
LZL 2 62 14(6) 3 
OLGA 31 62 8 4 
OLL 31 62 8 4 
PF040 15 1 8 3 2 
PITOUT 29 44 7 2 
PMG075 3 14 1 5 
SA 24 5 1 5 
SCHU 3 7 15(2) 6 
SLEOOS 2 60 13(6) 6 
SPACH 31 62 8 4 
SPL 31 62 8 4 
T7526 2 46 9 3 
T7527 2 46 9 3 
T IS! 24 35 11 (5) 3 
VAVY 1 8 3 2 
WIN 1 57 7 3 
J C 2 62 4 3 
NK 1,11 57,27 4,7 2,3 
HB 2,11 57,35 1,7 1,2 
WH 2,26 37,38 4,6 1,3 
specific ity that was abse nt on those that did not. Prev io us stud ies in 
mouse [39-41] and human [42-47] models indicate that minor 
HLA anti gens a re capable of e lic iting imm une responses and that 
these antigens could sh are som e level of res tricting e lem ents, e.g., 
HLA anti ge ns. In our study, th e proliferation of skin-infiltratin g 
ce ll s was co nsistent w ith response to minor HLA antigens, but 
w h ether th ese hypoth es ized antigens a re ti ssue antigens expressed 
in the skin by cell s such as keratinocytes or Langerhans cells is not 
known. O ne thin g tha t is evident is that most of the cell lines that 
strongly stimulated the ce ll cultu res did share at least o ne HLA 
antige n w ith the patie nts' ce lls. Other cells that did no t stimubte 
also sh ared certain HLA anti ge ns with th e patients, but did not 
stimul ate presumabl y because they did not carry th e re levant mino r 
Table II. B ulk PL T Restimulatio n of Cells C ultured from 
Invo lved Sk in of Patient 1 
HLA• 
Secondary 
Stimulator A B DR DQ DP % RNV6 
Autologous 2 62 4 3 159' 
PMG 3 14 1 1 3,4 163 
BOB 2 62 4 3 4B? 122 
BM92 is 62 4 3 4B? 235 
J BUSH 32 38 5 3 4 100 
LZL 2 62 14 3 4B? 155 
EHM 3 35 1 1 4 175 
OLGA 31 62 8 4 3,4? 100 
BRIP 9 5 5 3 2,4B 100 
T7526 2 46 9 3 ? 287 
SLE 2 60 6 1 3 583 
N- = 29J 
• HLA antigens of LCL shared with patient arc underl ined. 
b Resu lts expressed as responder-normalized value equating the 75th ranked response 
to I 00%. Only LCL that elicited a positive response arc shown. 
' Average of two different experiments. 
J Number of LCL tested that shared varying number of HLA an ti gens with the 
patient. 
SKIN-INFILTRATING CELLS lN PSORIASIS 7 
Table III. Bulk PLT Restimulation of Cells Cultured from 
Involved Skin of Patient 2 
H LA• 
Secondary 
Stimulator A B DR DQ DP % RNV6 
Autologous 2,11 57,35 1,7 1.2 1529' 
SA 24 5 1 1 4B? 198 
H 0 104 3 7 2 1 4 165 
J BUS H 32 38 5 3 4 100 
LZL 2 62 14 3 4B? 991 
PMG 3 14 1 1 3,4 397 
AMAI 28 5 2 1 1420 
SCHU 3 7 2 1 4B 274 
BM92 25 62 4 3 4B? 503 
BOB 2 62 4 3 4B? 100 
SLE 2 60 6 1 3 402 
WIN 1 57 7 3 4 117 
OLGA 31 62 8 4 3,4? 398 
N = 29d 
'HLA antigens of LCL shared with patient arc underlined. 
"Resul ts expressed as responder-normali zed va lue equatin g the 75th ranked response 
to 100%. Only LCL that elicited a positive response arc shown. 
' Average of two different experiments. 
J Number of LCL tested that shared vary ing number of HLA antigens with the 
patient. 
HLA antigen. This type of reactivity pattern is indicative of the 
recognition of mino r HLA antigens [42-49]. 
It should be noted that the m ajority of evidence for the invo lve-
ment of th e minor HLA anti gens in t h e immune response is from 
studies of leukemic patients w h o received bone marrow transplants 
form HLA-iden tica l siblin gs [38-45]. T h e skin-infiltrati n g cells 
o btained from sites of gra ft -vs- h ost revealed ch aracteristics similar 
to the infiltratin g cell s demonstrated in this study [47]. Such an 
observation by no m eans indica tes recognition of the same antigen 
in psoriasis patients as in those with GVH disease. However, the 
similar p atte rn of reactivity may represent recognitio n of the minor 
HLA antigens. Whether these antigens are t he same is doubtful and 
remains to be determined. 
An alternative possibility is the involvement of microbial anti-
ge ns in activation of infi ltrating cells. H owever, it h as been demon-
strated that DR, DQ, and DP in those cases serve as restriction 
e lements [50-54]. Results of o u r PLT do not show such restrict ion 
Table IV. Bulk PLT R estimulation of Ce lls C ul tured from 
Involved Skin of Patient 3 
HLA" 
Secondary 
Stimulator A B DR DQ DP % RNV6 
Autologous 1 '11 57,27 4,7 2,3 1523' 
BM92 25 62 4 3 4B? 108 
VAVY 1 8 3 2 1 100 
TIS! i4 35 5 3 4B? 179 
J BUSH 32 38 5 3 4 415 
LZL 2 62 14 3 4B? 11 2 
OLL 31 62 8 4 3,4B? 152 
EHM 3 35 1 1 4 103 
PMG 3 14 1 1 3,4 152 
BOB 2 62 4 3 4B? 100 
BRIP 9 5 5 3 2,4B 164 
OLGA 31 62 8 4 3,4? 184 
T7526 2 46 9 3 249 
N = 29J 
' HLA antige ns of LCL shared with patient arc underlined. 
b Results expressed as responder-normalized value equating the 75th ranked response 
to 100%. Onl y LCL that el icited a positive response arc shown. 
' Average of two different experiments. 
J Number of LCL tested that shared varying number of HLA antigens with the 
patient. 
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Table V. Bulk PLT Restimulation of Cells Cultured from 
Uninvolved Skin of Patient 4 
HLA• 
Secondary 
% RNVb Stimulator A B DR DQ DP 
Autologous 2,26 27,38 4,6 1,3 5988 
BM92 25 62 4 3 4B? 100 
LZL 2 62 6 3 4B? 108 
BER 2 13 7 2 2,4? 103 
T7526 2 46 
N-=29• 
9 ~ 142 
• HLA antigens of LCL shared with patient arc underlined. . 
I Results expressed as responder-normalized value equating the 75th ranked response 
to 100%. Only LCL that elicited a positive response arc shown. 
'N umber of LCL tested that shared varying number of HLA antigens with the 
patient. 
and therefore argue against the possible involvement of microbial 
antigens. . 
It may also be possible that the skin-infiltrated cells recogmze 
peptide(s) located in the groove of the HLA molecule as reported by 
Bjorkman eta! (55,56], and that this peptide is expressed on those 
cell lines that induced restimulation of skin cultures in the PLT 
assay. The ongoing clonal expansion of these cells and identification 
of T cell receptors should help to define the nature of the antigens 
described above in skin of psoriasis patients. 
In summary, this study reveals the presence of activated T lym-
phocytes in both involved and uninvolved skin of ps?riasis patients. 
These lymphocytes are autoreactive and may recogmze mmor HLA 
determinants . 
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